Diamond Biofund Inc.

Taiwan Stock Exchange 6901.TW

Diamond Biofund Inc. Revenue for the year ending December 31, 2023: USD 73.10 K

Diamond Biofund Inc. Revenue is USD 73.10 K for the year ending December 31, 2023, a -99.78% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Diamond Biofund Inc. Revenue for the year ending December 31, 2022 was USD 33.13 M, a 0.00% change year over year.
  • Diamond Biofund Inc. Revenue for the year ending December 31, 2021 was USD 0.00, a 0.00% change year over year.
  • Diamond Biofund Inc. Revenue for the year ending December 31, 2020 was USD 0.00, a 0.00% change year over year.
  • Diamond Biofund Inc. Revenue for the year ending December 31, 2019 was USD 0.00.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Taiwan Stock Exchange: 6901.TW

Diamond Biofund Inc.

CEO Mr. Pan-Chih Yang
IPO Date Sept. 11, 2023
Location
Headquarters 34th Floor
Employees 28
Sector Finance
Industries
Venture Capital Biotechnology
Description

Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email